Related Experiment Video
Updated: Aug 8, 2026

Isolation of Fidelity Variants of RNA Viruses and Characterization of Virus Mutation Frequency
Published on: June 16, 2011
Mutations in VP1 of poliovirus specifically affect both encapsidation and release of viral RNA
1Department of Molecular, Cellular and Developmental Biology, University of Colorado, Boulder 80309.
Abstract:
The phenotypic defects of two type 1 Mahoney poliovirus mutants, termed VP1-101 and VP1-102, were caused by two different small deletions in the region of the RNA genome encoding the amino terminus of the capsid protein VP1. This portion of VP1 was unresolved in the three-dimensional structure of the poliovirion, buried within the virion, and likely to interact with the viral RNA. Both VP1-101 and VP1-102 showed a diminished ability to enter CV1 but not HeLa cells; both mutants formed plaques on CV1 and HeLa cells that were smaller than wild type. Neither the rate of binding to cells nor the rate of subsequent receptor-dependent conformational change of the mutant poliovirions was affected. However, both mutants displayed delayed kinetics of RNA release compared with wild-type virus. One of the mutants, VP1-102, also displayed a defect in viral morphogenesis: 75S empty capsids formed normally, but 150S particles that contained RNA accumulated much more slowly. We suggest that the VP1-102 mutation affects RNA encapsidation as well as RNA release, whereas the VP1-101 mutation affects only RNA release. Therefore, RNA packaging and RNA release are genetically linked but can be mutated separately in different VP1 alleles, and both processes involve the amino terminus of VP1.
Insights
Poliovirus mutants with defects in VP1 protein show impaired RNA release and entry into cells. These findings suggest RNA packaging and release are linked processes involving the VP1 amino terminus.
Area of Science:
- Virology
- Molecular Biology
- Structural Biology
Background:
- Poliovirus type 1 Mahoney mutants, VP1-101 and VP1-102, exhibit phenotypic defects.
- These defects stem from deletions in the N-terminal region of the capsid protein VP1.
- This VP1 region is internal to the virion and interacts with viral RNA.
Purpose of the Study:
- To investigate the functional role of the VP1 amino terminus in poliovirus replication.
- To determine the specific defects caused by mutations in the VP1 N-terminus.
- To elucidate the relationship between RNA packaging, release, and viral morphogenesis.
Main Methods:
- Characterization of poliovirus mutants VP1-101 and VP1-102.
- Analysis of viral entry into CV1 and HeLa cells.
- Plaque assays to assess viral replication.
- Kinetics studies of RNA release and viral morphogenesis.
Main Results:
- Mutants VP1-101 and VP1-102 showed reduced entry into CV1 cells and smaller plaque sizes.
- Cell binding and conformational changes were unaffected, but RNA release was delayed.
- VP1-102 mutant displayed defects in viral morphogenesis, with slower accumulation of RNA-containing particles.
- VP1-101 mutation primarily affected RNA release, while VP1-102 affected both RNA release and encapsidation.
Conclusions:
- The amino terminus of poliovirus VP1 is crucial for both RNA release and, in some cases, RNA encapsidation.
- RNA packaging and RNA release are genetically linked but can be independently mutated.
- These processes involve the VP1 N-terminal region, highlighting its importance in the viral life cycle.
Related Concept Videos
Viral Mutations
Leaky Scanning
Size and Structure of Viral Genomes
Viruses with RNA Genomes
Inhibitors Of Virion Release
Inhibitors of Virion Maturation and Assembly

